Khursheed Anwer - Sep 10, 2024 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role
Chief Scientific Officer
Signature
/s/ Kimberly Graper, VP of Finance & Controller
Stock symbol
IMNN
Transactions as of
Sep 10, 2024
Transactions value $
$0
Form type
4
Date filed
9/10/2024, 04:46 PM
Previous filing
Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Stock Option (Right to Buy) Award $0 +40.7K +30.6% $0.00 173K Sep 6, 2024 Common Stock 40.7K $1.04 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.
F2 Represents the closing price of Imunon, Inc. Common Stock on the date of grant.
F3 Option granted in lieu of cash payment increases.